Tech Company Financing Transactions
ResBiotic Funding Round
On 5/3/2021, ResBiotic announced $3 million in Seed funding from Timberline Holdings and private investors.
Transaction Overview
Company Name
Announced On
5/3/2021
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Seed
Investors
Timberline Holdings (Lead Investor)
Proceeds Purpose
The company intends to use the funds for the development and commercialization of probiotic formulations for lung health.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1500 1st Ave. N H102
Birmingham, AL 35203
USA
Birmingham, AL 35203
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
After years of research, we can now modulate how the microbiota influence lung diseases. ResBiotic is developing first-in-class products that alleviate the neutrophilic inflammation associated with dysbiosis to improve respiratory health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Medical Officer
Amit Gaggar
Chief Operating Officer
Andrew O'Connor
Founder
Vivek Lal
VP - Bus. Development
Scott Bush
Browse more venture capital transactions:
Prev: 4/30/2021: Forge Biologics venture capital transaction
Next: 5/3/2021: Sorbet venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs